Human Biotechnology: Responding to Emerging Dangerous New Human Genetics
By Jesse Reynolds,
Z Magazine
| 03. 31. 2003
As 2003 began, the mainstream press was grappling with a cloning hoax. This January, it launched extended coverage of the 50th anniversary of the identification of DNA's structure. Both events provided golden opportunities to deepen public understanding of the social and political implications of new human genetic and reproductive technologies.
Unfortunately, the media have mostly flubbed these opportunities. The coverage of the Raelians' cloning claims obscured rather than illuminated the critical issues. Early signs on the second media opportunity-a series of carefully planned celebrations throughout the spring-are none too promising. Fortunately, a civil society response to dangerous new human genetic and reproductive technologies is emerging in a number of countries, as witnessed at January's World Social Forum in Brazil.
The year's first human biotechnology media frenzy actually began at the end of December 2002, when a previously obscure alien-chasing sect announced that its scientists had produced the world's first human clone. The initial news reaction appropriately focused on whether the claim could be true. But by the time the Raelians' excuses as to why they were unable to show the...
Related Articles
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...